News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Allied Minds Announces Completion Of Its Initial Public Offering And Admission To The London Stock Exchange


7/24/2014 11:13:50 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOSTON--(BUSINESS WIRE)--Allied Minds plc (LSE: ALM) today announced that its entire issued ordinary share capital of 213,290,579 ordinary shares was recently admitted to the premium listing segment of the Official List of the UK Listing Authority and to trading on the London Stock Exchange's Main Market for listed securities under the ticker "ALM" (ISIN: GB00BLRLH124).

The admission followed the successful pricing of its initial public offering at 190 pence per ordinary share, which provided the Company with a total market capitalization of approximately £405.3 million ($691.1 million), based on the per share price at the commencement of conditional dealings on June 20, 2014. The Company sold 44,254,411 new ordinary shares in the offering, plus 3,791,154 new ordinary shares pursuant to an over-allotment option, and selling shareholders sold 17,440,797 existing ordinary shares, resulting in total gross proceeds raised in the offering of approximately £124.4 million ($212.2 million). Jefferies International Limited acted as sole sponsor and bookrunner.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES